InvestorsHub Logo
Followers 282
Posts 13918
Boards Moderated 0
Alias Born 05/21/2014

Re: eagle_2975 post# 57714

Wednesday, 07/30/2014 7:47:50 AM

Wednesday, July 30, 2014 7:47:50 AM

Post# of 91950
PMBS .0004 adding Hemp and THC-Free Cannabis http://www.puramedbioscience.com/2014/03/24/puramed-bioscience-explores-the-development-of-hemp-and-thc-free-cannabis-formulations-to-expand-its-product-line/



“Integrating cannabinoid-based medications into our product line makes sense with what we are already doing,” said Russell Mitchell, CEO of PuraMed BioScience. “Cannabis has been used medicinally for centuries. It has only been in the last 100 years that its schedule 1 drug status and the abuse of this product for non-medicinal purposes has detracted from its medicinal benefits. Medical journal publication sites list many medical articles that report cannabinoids provide a viable treatment to neurologic problems, inflammatory diseases, and pain.

“Due to recent changes in the legality and availability of cannabinoids, we believe the future looks extremely bright for the development of highly effective and safe treatments incorporating these hemp derived compounds,” said Mitchell.

Scientific evidence continues to grow as to the effectiveness and safety of certain cannabinoids used to treat a number of disease states. In his article, ‘I am doubling down’ on medical marijuana, published on CNN Health, Dr. Sanjay Gupta, practicing neurosurgeon and CNN Chief Medical Correspondent, confirms his previous article apologizing for dismissing the plant’s potential.

Dr. Gupta has seen first-hand the benefit of this substance in the lives of people as shown in his documentaries Weed and Weed2, which recently aired on CNN. During his documentaries, Dr. Gupta stated that, unlike some prescription pain relievers, no one has died from an overdose of cannabis.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.